Live feed16:32:02·3dINSIDERFilingvia QuantisnowDirector Bumpus Namandje was granted 88,424 shares and sold $12,602 worth of shares (3,963 units at $3.18) as part of a pre-agreed trading plan, increasing direct ownership by 196% to 127,632 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.RXRX· Recursion Pharmaceuticals Inc.Health CareOriginal source
